Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,690,741
Closed -$160M 36
2025
Q1
$160M Buy
2,690,741
+91,010
+4% +$5.77M 1.9% 21
2024
Q4
$157M Sell
2,599,731
-80,114
-3% -$4.9M 1.89% 21
2024
Q3
$193M Buy
2,679,845
+12,483
+0.5% +$872K 2.21% 18
2024
Q2
$188M Buy
2,667,362
+48,393
+2% +$3.72M 2.34% 18
2024
Q1
$209M Sell
2,618,969
-47,104
-2% -$3.8M 2.8% 17
2023
Q4
$239M Sell
2,666,073
-19,083
-0.7% -$1.64M 3.6% 13
2023
Q3
$265M Buy
2,685,156
+88,956
+3% +$9.19M 4.49% 12
2023
Q2
$265M Buy
2,596,200
+54,265
+2% +$5.37M 4.41% 12
2023
Q1
$285M Buy
+2,541,935
New +$281M 5.17% 9

Other funds holding APTV

Mirova US's APTV Position: Q2 2025 in Review

Mirova US sold out of Aptiv (APTV) in Q2 2025, closing a stake of 2,690,741 shares — an estimated $160M sold.

Mirova US first reported a position in APTV in Q1 2023 and held it in 9 quarters. The position peaked at $285M in Q1 2023. 635 funds tracked by Wall St. Rank hold APTV as of Q2 2025.

  • Mirova US reported no remaining Aptiv position as of Q2 2025 after selling out during the quarter.
  • Mirova US sold 2,690,741 Aptiv shares in Q2 2025, an estimated $160M.
  • Mirova US first reported a position in Aptiv in Q1 2023 and held it in 9 quarters.
  • Mirova US's Aptiv position peaked at $285M in Q1 2023.
  • 635 funds tracked by Wall St. Rank held Aptiv as of Q2 2025.

Based on Mirova US's 13F filing for Q2 2025, filed 23 Jul 2025.